uniQure N.V. Ordinary Shares vs Telus Corporation Ordinary Shares — how do they compare? uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B), while Telus Corporation Ordinary Shares trades at $8.11 (market cap $12.52B). The key difference: Telus Corporation Ordinary Shares is far larger — about 8.5× uniQure N.V. Ordinary Shares's market cap, and Telus Corporation Ordinary Shares pays a 6.59% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Telus Corporation Ordinary Shares for 0 Days on average.
| QURE | TU | |
|---|---|---|
Market Cap | $1.48B | $12.52B |
Volume | 2,488,780 | 6,655,034 |
Sector | Health | Media |
52-Week High | $70.59 | $15.33 |
52-Week Low | $9.03 | $7.72 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $728.62M | $33.57B |
Dividend Yield | — | 6.59% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →Telus Corporation is a Canadian telecommunications company providing wireless, internet, television, and business connectivity services, with additional operations in digital healthcare through Telus Health and customer experience services through Telus Digital.
Read more on TU →